A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
Helmy M SiragyProfessor of Medicine and Endocrinology, Department of Medicine, Director, Hypertension Center, University of Virginia Health System, Charlottesville, VA, USAAbstract: The safety of angiotensin II receptor blockers (ARBs) for the treatment of hypertension and cardiovascular and renal d...
Main Author: | Siragy H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-05-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/a-current-evaluation-of-the-safety-of-angiotensin-receptor-blockers-an-peer-reviewed-article-VHRM |
Similar Items
-
The renin-angiotensin system and its blockers
by: Igić Rajko, et al.
Published: (2014-01-01) -
Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
by: Karl Andersen
Published: (2009-03-01) -
Renin inhibitors are a new direction in the treatment of arterial hypertension
by: Yuriy Aleksandrovich Vasyuk, et al.
Published: (2010-09-01) -
Beta-Blocker and Renin–Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study
by: Yong Hoon Kim, et al.
Published: (2020-10-01) -
Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01)